\BOOKMARK [0][-]{chapter*.4}{Index of figures}{}% 1
\BOOKMARK [0][-]{chapter*.5}{List of tables}{}% 2
\BOOKMARK [0][-]{chapter.1}{Introduction}{}% 3
\BOOKMARK [1][-]{section.1.1}{Protein overview}{chapter.1}% 4
\BOOKMARK [2][-]{subsection.1.1.1}{Protein structure}{section.1.1}% 5
\BOOKMARK [2][-]{subsection.1.1.2}{Protein function}{section.1.1}% 6
\BOOKMARK [2][-]{subsection.1.1.3}{Protein-Ligand Interactions}{section.1.1}% 7
\BOOKMARK [2][-]{subsection.1.1.4}{Protein-ligand prediction}{section.1.1}% 8
\BOOKMARK [1][-]{section.1.2}{Drug discovery}{chapter.1}% 9
\BOOKMARK [2][-]{subsection.1.2.1}{subsection}{section.1.2}% 10
\BOOKMARK [1][-]{section.1.3}{Drug discovery}{chapter.1}% 11
\BOOKMARK [2][-]{subsection.1.3.1}{In-silico methods in drug-discovery}{section.1.3}% 12
\BOOKMARK [1][-]{section.1.4}{Mycobacterium tuberculosis}{chapter.1}% 13
\BOOKMARK [2][-]{subsection.1.4.1}{Tuberculosis treatments and PPcs}{section.1.4}% 14
\BOOKMARK [1][-]{section.1.5}{Drug resistance in cancer}{chapter.1}% 15
\BOOKMARK [2][-]{subsection.1.5.1}{Cancer Treatment and drugs}{section.1.5}% 16
\BOOKMARK [0][-]{chapter.2}{Objectives}{}% 17
\BOOKMARK [0][-]{chapter.3}{nAnnolyze}{}% 18
\BOOKMARK [0][-]{chapter.4}{Predicting targets in MTB}{}% 19
\BOOKMARK [0][-]{chapter.5}{Drug resistance in cancer}{}% 20
